Many authors have confirmed these findings in BC since the initial research of raised serum VEGF in oncologic patients (Kondo et al., 1994), with higher levels typically identified in metastatic or advanced disease compared to early BC (Będkowska et al., 2021, Kamil et al., 2021). Here, VEGFA is linked to breast cancer.